Next Science Ltd (AU:NXS) has recently announced an important update regarding its sales force restructuring. The company has made changes to its sales team in order to reduce costs and improve efficiency, with the goal of saving approximately US$6 million annually.
Despite these changes, Next Science Ltd has reported an increase in product sales and a strong gross margin. This has given the company confidence in meeting its FY24 revenue guidance of US$36m-$40m. Furthermore, Next Science Ltd anticipates achieving EBITDA and cashflow positivity in the second half of the fiscal year.
The strategic shift in the sales force includes transitioning to a flexible, commission-based structure. This change is part of Next Science Ltd’s efforts to capitalize on new market opportunities and drive future growth. Investors interested in learning more about AU:NXS stock can visit TipRanks’ Stock Analysis page for additional insights.
In a major victory for the state of Oregon, a U.S. District Court judge in…
Georgian President Salome Zurabishvili has vetoed the bill “On Transparency of Foreign Influence” that was…
Vietnam's pharmaceutical industry is currently meeting about 60% of the demand for preventive and curative…
Over the past 25 years, Tasjeel centers of ENOC group have completed over 20 million…
Valerie Bertinelli announced on Instagram that she will be taking a break from social media…
On Wednesday, the Gulf Cooperation Council (GCC) region experienced a mixed performance in their stock…